McGrath, L. J., Kim, M., Pritchard, D., Yu, Y., Samai, P., Balasubramanian, A., … Brookhart, M. A. (2021). Using negative control outcomes to assess the comparability of treatment groups among postmenopausal women switching osteoporosis therapy. In PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (Vol. 30, pp. 389–390).

McGrath, Leah J., Min Kim, David Pritchard, Ying Yu, Peter Samai, Akhila Balasubramanian, Jay Lin, et al. “Using negative control outcomes to assess the comparability of treatment groups among postmenopausal women switching osteoporosis therapy.” In PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 30:389–90, 2021.

McGrath LJ, Kim M, Pritchard D, Yu Y, Samai P, Balasubramanian A, et al. Using negative control outcomes to assess the comparability of treatment groups among postmenopausal women switching osteoporosis therapy. In: PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. 2021. p. 389–90.

McGrath, Leah J., et al. “Using negative control outcomes to assess the comparability of treatment groups among postmenopausal women switching osteoporosis therapy.” PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, vol. 30, 2021, pp. 389–90.

McGrath LJ, Kim M, Pritchard D, Yu Y, Samai P, Balasubramanian A, Lin J, Spangler L, Stad R, Bradbury BD, Brookhart MA. Using negative control outcomes to assess the comparability of treatment groups among postmenopausal women switching osteoporosis therapy. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. 2021. p. 389–390.